Invacare 2013 Annual Report Download - page 42

Download and view the complete annual report

Please find page 42 of the 2013 Invacare annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 140

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140

I-36
PART II
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities.
Invacare’s Common Shares, without par value, trade on the New York Stock Exchange (NYSE) under the symbol “IVC.”
Ownership of the Company’s Class B Common Shares (which are not listed on NYSE) cannot be transferred, except, in general,
to family members without first being converted into Common Shares. Class B Common Shares may be converted into Common
Shares at any time on a share-for-share basis. The number of record holders of the Company Common Shares and Class B Common
Shares at February 25, 2014 was 2,618 and 26, respectively. The closing sale price for the Common Shares on February 25, 2014
as reported by NYSE was $19.61. The prices set forth below do not include retail markups, markdowns or commissions.
The range of high and low quarterly prices of the Common Shares and dividends in each of the two most recent fiscal years
were as follows:
2013 2012
High Low Cash Dividends
Declared High Low Cash Dividends
Declared
Quarter Ended:
December 31 . . . . . . . . . . . . $ 23.21 $ 16.54 $ 0.0125 $ 16.45 $ 12.98 $ 0.0125
September 30 . . . . . . . . . . . . 17.46 14.53 0.0125 17.15 13.37 0.0125
June 30 . . . . . . . . . . . . . . . . . 16.23 11.11 0.0125 16.54 14.21 0.0125
March 31 . . . . . . . . . . . . . . . 17.18 12.84 0.0125 17.94 15.49 0.0125
During 2013 and 2012, the Board of Directors also declared annualized dividends of $0.045 per Class B Common Share.
For information regarding limitations on the payment of dividends in the Company loan and note agreements, see Long Term
Debt in the Notes to the Consolidated Financial Statements included in this report. The Common Shares are entitled to receive
cash dividends at a rate of at least 110% of cash dividends paid on the Class B Common Shares. See Item 7. Management's
Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources, regarding covenants
in the Company's senior credit facility with respect to the payment of dividends.